Pillar Biosciences
PrivateLast Round
Strategic
May 27, 2025
Total Funding Raised
$82.2M
Momentum Score
25 /100
Company Overview
Pillar Biosciences, founded in 2014, is a clinical cancer diagnostics company that develops and manufactures next-generation sequencing (NGS) solutions to make precision medicine more accessible. The company provides kitted NGS panels and proprietary bioinformatics software, utilizing its SLIMamp® and PiVAT® technologies, which enable clinical laboratories to perform rapid, in-house tumor profiling. This approach helps to identify genetic variants, optimize therapy selection for cancer patients, and reduce diagnostic costs. Headquartered in Natick, Massachusetts, Pillar Biosciences has established strategic partnerships with major life sciences companies, including Illumina and AstraZeneca, to expand the global reach of its diagnostic products.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotech Equipment, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pillar Biosciences Comps
Public and private peers based on sector, stage, and business model.
Pillar Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 27, 2025 | ||||
| Series C | May 12, 2020 | ||||
| Series A | May 11, 2016 |
Pillar Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Soleus Capital | Strategic |
| ORI Healthcare Fund | Series A, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Partnered with CellCarta for global tumor profiling.
- Oct 23, 2025
Attending the 2025 Association for Molecular Pathology Annual Meeting.
Pillar Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pillar Biosciences's valuation, stock price, and market status.
